企業プロフィール
Genenta Science 株価・ニュース・カタリスト
- ティッカー:
- GNTA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- Italy and listed in the U
株価パフォーマンス
1.26 USD (+5.88%)
終値
最終更新: 2026年8月21日
51.9M USD
時価総額
株価変動の要因
As of Aug 21, 2026, GNTA closed up 5.88% at $1.26. No new same-company headline was identified in the current news window.
企業概要
事業概要
Genenta Science is a cell-therapy company focused on engineered myeloid cells and cancer immunotherapy. Its platform aims to create a new class of cellular medicine for oncology.
所在地とセクター分類
Headquartered in Italy and listed in the U.S. as an ADR, Genenta has a global cell-therapy profile.
ビジネスモデルの特徴
The company depends on platform validation, clinical data, and the ability to turn engineered-cell science into oncology value.
バイオ業界での位置付け
Genenta is a high-catalyst cell-therapy name whose stock reacts to translational and clinical milestones.
今後のカタリスト
- Genenta’s catalysts are its onco-immunology platform and any data that show the hematology / solid-tumor approach can still advance. The company remains early and data-dependent.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。